Dose-escalation of locally advanced non-small cell lung cancer with proton beam therapy

Vivek Verma, Joe Y. Chang


We appreciate the thoughtful comments by Drs. Hegde and Walker regarding the phase II study of concurrent chemotherapy and dose-escalated proton beam therapy (PBT) for locally advanced unresected non-small cell lung cancer (NSCLC) (1). There are several discussion points that we would like to add in tandem with the aforementioned correspondence.